In vitro activity of BMY-28100, a new oral cephalosporin.
The activity of BMY-28100, a new orally administered cephalosporin, was compared with those of cephalexin and cefaclor. BMY-28100 was the most active drug against Staphylococcus aureus (MIC for 90% of strains tested [MIC90], 1.0 microgram/ml), streptococci (MIC90S, less than or equal to 0.125 microg...
Saved in:
| Published in: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology (ASM)
1987
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174801/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3496846/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.4.653 |
| Tags: |
No Tags, Be the first to tag this record!
|